AstraZeneca and Gilead explore possibility of merger
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Pharma company expects disruption to peak in second quarter
Bristol-Myers Squibb’s acquisition of Celgene goes ahead after Amgen pays €13.4bn for drug
Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland
Company desperate to fill gap for its blockbuster arthritis drug Humira which loses patent protection in 2023
Investors hedge bets ahead of expected US-China trade talks on sidelines of G20
The Iseq all-share index rose just under 1.5%, buoyed by stocks with building exposure
Iseq rose 0.76%, buoyed by financials and CRH, outperforming peers
The move to buy Loxo Oncology is the second multibillion-dollar cancer deal of the year by a major US pharma giant
Iseq falls on thin trading volumes though Kerry Group ahead by 2.4 per cent
Transaction will be one of largest in history of pharma sector
Life-sciences company recently acquired rights to breakthrough drug
Buyer is surgeon turned biotech billionaire Patrick Soon-Shiong
New lower income-tax rate encourages US companies to repatriate billions of dollars in foreign profits held abroad
Paddy Power Betfair fell more than 2 per cent in London, as fears of a UK government clampdown weighed on gambling sector
Treatment ‘almost miraculous’ in successfully targeting childhood leukaemia
Ireland’s benchmark index ticked up by 1.08%, Cairn Homes and ICG perform well
Ireland’s benchmark index drops marginally, performs better than Europe’s Stoxx 600
Also, pioneering system for wound closures shortens time by up to 80 per cent and reduces the risk of infection and scarring
Dollar retreats from 14-year-high against euro as oil fluctuates ahead of Christmas break
Irish financials buoyed by global rally with Bank of Ireland and PTSB both closing up
Losses in technology stocks in New York drag down Nasdaq and S&P 500
Sanofi, Merck, Celgene and Gilead Sciences also believed to have been interested in firm
Iseq down 1.75 per cent with Bank of Ireland, Fyffes, Kerry and Origin among the fallers
European shares rise after three grim days, with financial stocks leading the way
Kingspan most notable gainer in Dublin while Permanent TSB slips 7 per cent
In Dublin, Paddy Power shares rise to nearly €136 ahead of merger with Betfair
US stocks fluctuate as advance of biotechnology shares offsets continued selling in energy producers
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices